Abstract
We previously found an inverse relationship between sialidase Neu1 expression and metastatic potential of murine cancer cells. To elucidate the mechanism underlying the cellular events, the human sialidase gene NEU1 was overexpressed or silenced in colon cancer HT-29 cells. When NEU1-overexpressing cells were injected transsplenically into mice, in vivo liver metastasis was significantly reduced. NEU1 suppressed cell migration, invasion and adhesion in vitro, whereas the silencing resulted in the opposite. One of the major molecular changes by NEU1 was decreased sialylation of integrin β4, assessed by PNA- and MAL-II-lectin blotting of immunoprecipitates with anti-integrin β4 antibody. The desialylation was accompanied by decreased phosphorylation of the integrin followed by attenuation of focal adhesion kinase and Erk1/2 pathway. Moreover, NEU1 caused downregulation of matrix metalloproteinase-7, overexpression of which is associated with cancer metastasis. Treatment of the cells with GalNAc-α-O-benzyl, an inhibitor of O-glycosylation, showed increased PNA-positive integrin β4 with its decreased phosphorylation, indicating that sialic acid removal from the integrin O-glycans results in the decreased phosphorylation. Biotinylation and immunofluorescence staining exhibited some NEU1 molecules to be at the cell surface accessible to the integrin. These results suggest that NEU1 is important in regulation of integrin β4-mediated signaling, leading to suppression of metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dennis JW, Granovsky M, Warren CE . (1999). Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1473: 21–34.
Duca L, Blanchevoye C, Cantarelli B, Ghoneim C, Dedieu S, Delacoux F et al. (2007). The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem 282: 12484–12491.
Fukushima Y, Ohnishi T, Arita N, Hayakawa T, Sekiguchi K . (1998). Integrin α3β1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 76: 63–72.
Galjart NJ, Gillemans N, Harris A, van der Horst GT, Verheijen FW, Galjaard H et al. (1988). Expression of cDNA encoding the human ‘protective protein’ associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell 54: 755–764.
Giancotti FG, Ruoslahti E . (1999). Integrin signaling. Science 285: 1028–1032.
Giannelli G, Astigiano S, Antonaci S, Morini M, Barbieri O, Nooman DM et al. (2002). Role of the α3β1 and α6β4 integrins in tumor invasion. Clin Exp Metastasis 19: 217–223.
Hakomori S . (2002). New wine in an old bottle. Proc Natl Acad Sci USA 99: 10231–10233.
Hinek A, Pshezhetsky AV, von Itzstein M, Starcher B . (2006). Lysosomal sialidase (Neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J Biol Chem 281: 3698–3710.
Huet G, Hennebicq-Reig S, de Bolos C, Ulloa F, Lesuffleur T, Barbat A et al. (1998). GalNAc-α-O-benzyl inhibits NeuAc α2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus differentiated HT-29 cells. J Cell Biol 141: 1311–1322.
Julenius K, Mølgaard A, Gupta R, Brunak S . (2004). Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15: 153–164.
Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I et al. (2002). Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 99: 10718–10723.
Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K et al. (2006). Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signaling. Biochem J 394: 647–656.
Kato T, Wang Y, Yamaguchi K, Milner CM, Shineha R, Satomi S et al. (2001). Overexpressing of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells. Int J Cancer 92: 797–804.
Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M . (2005). Membrane-type matrix metalloproteinase-1(MT1-MMP) is a processing enzyme for human laminin γ2 chain. J Biol Chem 280: 88–93.
Li K . (1992). Determination of sialic acids in human serum by reversed-phase liquid chromatography with fluorimetric detection. J Chromatogr 579: 209–213.
Liang F, Seyrantepe V, Landry K, Ahmad R, Ahmad A, Stamatos NM et al. (2006). Monocyte differentiation upregulates the expression of the lysosomal sialidase, Neu1 and triggers its targeting to the plasma membrane via Major histocompatibility complex classII compartments. J Biol Chem 281: 27526–27538.
Lohi J . (2001). Laminin-5 in the progression of carcinomas. Int J Cancer 94: 763–767.
Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H et al. (2004). Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells. Clin Cancer Res 10: 8243–8249.
Miyagi T, Sato K, Hata K, Taniguchi S . (1994). Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity. FEBS Lett 349: 255–259.
Miyagi T, Tsuiki S . (1984). Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase. Eur J Biochem 141: 75–81.
Miyagi T, Wada T, Yamaguchi K, Hata K . (2004). Sialidase and malignancy: a minireview. Glycoconj J 20: 189–198.
Miyagi T, Wada T, Yamaguchi K . (2008). Roles of plasma membrane-associated sialidase NEU3 in human cancers. Biochim Biophys Acta 1780: 532–537.
Miyagi T, Yamaguchi K . (2007). Biochemistry of glycoconjugate glycans: sialic acids.In: Kamerling JP, Boons G, Lee YC, Suzuki A, Taniguchi N, Voragen AGJ (eds). Comprehensive Glycoscience. vol. 3. Elsevier BV: Amsterdam, The Netherlands, pp 297–322.
Monti E, Preti A, Venerando B, Borsani G . (2002). Recent development in mammalian sialidase molecular biology. Neurochem Res 27: 649–663.
Remacle AG, Chekanov AV, Golubkov VS, Savinov AY, Rozanov DV, Strongin AY . (2006). O-Glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP). J Biol Chem 281: 16897–16905.
Remy L, Trespeuch C, Bachy S, Scoazec J-V, Rousselle P . (2006). Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 β3 chain. Cancer Res 66: 11228–11237.
Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T et al. (2002). Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer 97: 180–185.
Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL . (2005). Hypersialylation of β1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 65: 4645–4652.
Shiomi T, Okada Y . (2003). MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 22: 145–152.
Trainer DL, Kline T, McCabe FL, Faucette LF, Field J, Chaikin M et al. (1998). Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287–296.
Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, Arai Y et al. (2006). Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes the interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 281: 7756–7764.
Wu YI, Munshi HG, Sen R, Snipas SJ, Salvesen GS, Fridman R et al. (2004). Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem 279: 8278–8289.
Xia Y, Gil SG, Carter WG . (1996). Anchorage mediated by integrin α6β4 to laminin-5 (Epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein. J Cell Biol 132: 727–740.
Yamaguchi K, Hata K, Koseki K, Shiozaki K, Akita H, Wada T et al. (2005). Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J 390: 85–93.
Zeng ZS, Shu WP, Cohen AM, Guillem JG . (2002). Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 8: 144–148.
Acknowledgements
We appreciate the expert technical assistance of Ms Setsuko Moriya. This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Uemura, T., Shiozaki, K., Yamaguchi, K. et al. Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin β4. Oncogene 28, 1218–1229 (2009). https://doi.org/10.1038/onc.2008.471
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.471
Keywords
This article is cited by
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
Clinical Epigenetics (2023)
Alteration of the neuronal and glial cell profiles in Neu1-deficient zebrafish
Glycoconjugate Journal (2022)
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
Oncogene (2022)
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Experimental Hematology & Oncology (2021)
Characterization of novel interactions with membrane NEU1 highlights new regulatory functions for the Elastin Receptor Complex in monocyte interaction with endothelial cells
Cell & Bioscience (2021)